Fig. 2.
Urinary oxytocin levels. Mean and standard deviation of urinary oxytocin levels at baseline (T1) and end of study (T2) time points in all study participants. As visible in A, MDD patients show lower urinary oxytocin levels at both time points without significant changes over time in both groups. Interestingly, this difference is mainly driven by patients not remitting under therapy, as only this group shows significantly lower oxytocin levels than controls (B)
